Expert Opinion on Drug Safety

1

Safety of topiramate for treating migraines

Marmura, Michael J

Journal:

Year:

2014

Language:

english

File:

PDF, 247 KB

english, 2014

2

A safety evaluation of ranibizumab in the treatment of age-related macular degeneration

Gibson, Jonathan Mark, Gibson, Stewart James

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 270 KB

english, 2014

3

Cardiovascular and ocular safety of α 1 -adrenoceptor antagonists in the treatment of male lower urinary tract symptoms

Oelke, Matthias, Gericke, Adrian, Michel, Martin C

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 559 KB

english, 2014

4

Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series

Dell’Osso, Bernardo, Cremaschi, Laura, Palazzo, Maria Carlotta, Spagnolin, Gregorio, Cattaneo, Alma, Grancini, Benedetta, Maggi, Matteo, Altamura, Alfredo Carlo

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 220 KB

english, 2014

5

Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?

Keen, Helen I, Krishnarajah, Janakan, Bates, Timothy R, Watts, Gerald F

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 358 KB

english, 2014

6

Understanding the safety and tolerability of facial filling therapeutics

Kulichova, Daniela, Borovaya, Alyona, Ruzicka, Thomas, Thomas, Peter, Gauglitz, Gerd G

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 652 KB

english, 2014

7

The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain

Maina, Giuseppe, Ripellino, Claudio

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 241 KB

english, 2014

8

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program

Castellano, Daniel, Antón Aparicio, Luis M, Esteban, Emilio, Sánchez-Hernández, Alfredo, Germà, Jose Ramón, Batista, Norberto, Maroto, Pablo, Pérez-Valderrama, Begoña, Luque, Raquel, Méndez-Vidal, Mar

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 290 KB

english, 2014

9

Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil

Lopes, Luciane Cruz, Silveira, Miriam Sanches do Nascimento, de Camargo, Mayara Costa, de Camargo, Iara Alves, Luz, Tatiana Chama Borges, Osorio-de-Castro, Claudia Garcia Serpa, Barberato-Filho, Silvi

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 296 KB

english, 2014

10

Calcium supplementation in chronic kidney disease

Taksande, Sushant Ramdas, Worcester, Elaine M

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 511 KB

english, 2014

11

Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation

Rutkowski, Piotr, Blank, Christian

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 370 KB

english, 2014

12

Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?

Genovesi, Simonetta, Gallieni, Maurizio

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 600 KB

english, 2014

13

Cardiac concerns associated with strontium ranelate

Reginster, Jean-Yves

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 493 KB

english, 2014

14

Comment on: sexual and fertility adverse effects associated with chemotherapy treatment in women

Blumenfeld, Zeev

Journal:

Expert Opinion on Drug Safety

Year:

2014

Language:

english

File:

PDF, 131 KB

english, 2014

Volume 13; Issue 9

Safety of topiramate for treating migraines

A safety evaluation of ranibizumab in the treatment of age-related macular degeneration

Cardiovascular and ocular safety of α 1 -adrenoceptor antagonists in the treatment of male lower urinary tract symptoms

Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series

Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?

Understanding the safety and tolerability of facial filling therapeutics

The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program

Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil

Calcium supplementation in chronic kidney disease

Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation

Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?

Cardiac concerns associated with strontium ranelate

Related articles

Comment on: sexual and fertility adverse effects associated with chemotherapy treatment in women